Rufomycin-1, Rufomycin B

General Information


DRACP ID  DRACP04117

Peptide Name   Rufomycin-1, Rufomycin B

Sequence  XXXAXLX

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C9H8N2O-2

Absent amino acids  CDEFGHIKMNPQRSTVWY

Common amino acids  X

Mass  76938

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  673

Hydrophobicity  80

Aliphatic Index  70

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30602512

Title  Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M abscessus

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17213

DRACP is developed by Dr.Zheng's team.